David Roman
Stock Analyst at Goldman Sachs
(3.65)
# 2,142
Out of 5,010 analysts
244
Total ratings
52.5%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $23.48 | -10.56% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $19.41 | -2.11% | 7 | Jul 15, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $19 → $21 | $17.14 | +22.52% | 4 | Jul 14, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $57 | $43.88 | +29.90% | 11 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $9.02 | +243.68% | 2 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $21 → $16 | $16.57 | -3.44% | 7 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $95 → $98 | $88.08 | +11.26% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $412.18 | +35.38% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $26 → $25 | $19.37 | +29.07% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $84 → $83 | $87.09 | -4.70% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $24 | $20.04 | +19.76% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $113 | $100.95 | +11.94% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $89 → $88 | $87.25 | +0.86% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $73 → $61 | $56.63 | +7.72% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 → $205 | $132.84 | +54.32% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $5.75 | +39.13% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $158.55 | -3.50% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $26.52 | -9.50% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $86.64 | -7.66% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $18.79 | +6.44% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $72 | $76.99 | -6.48% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $50 | $34.98 | +42.94% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $14.09 | +13.56% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54 → $66 | $89.32 | -26.11% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $357 → $361 | $278.77 | +29.50% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $66.46 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $147 | $114.22 | +28.70% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $181.97 | -8.23% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $28.46 | -40.27% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $93 → $88 | $91.34 | -3.66% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $75.69 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $105.80 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $103 | $98.99 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $15 | $9.54 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $23.48
Upside: -10.56%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $19.41
Upside: -2.11%
Bausch + Lomb
Jul 14, 2026
Reiterated: Hold
Price Target: $19 → $21
Current: $17.14
Upside: +22.52%
Boston Scientific
Jul 14, 2026
Reiterated: Buy
Price Target: $71 → $57
Current: $43.88
Upside: +29.90%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $9.02
Upside: +243.68%
Tandem Diabetes Care
Jul 14, 2026
Reiterated: Hold
Price Target: $21 → $16
Current: $16.57
Upside: -3.44%
Edwards Lifesciences
Jun 15, 2026
Reiterated: Buy
Price Target: $95 → $98
Current: $88.08
Upside: +11.26%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $412.18
Upside: +35.38%
Omada Health
Jun 10, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $19.37
Upside: +29.07%
Medtronic
Jun 4, 2026
Reiterated: Hold
Price Target: $84 → $83
Current: $87.09
Upside: -4.70%
Jun 3, 2026
Reiterated: Buy
Price Target: $14 → $24
Current: $20.04
Upside: +19.76%
May 31, 2026
Reiterated: Buy
Price Target: $121 → $113
Current: $100.95
Upside: +11.94%
May 29, 2026
Reiterated: Sell
Price Target: $89 → $88
Current: $87.25
Upside: +0.86%
May 27, 2026
Reiterated: Sell
Price Target: $73 → $61
Current: $56.63
Upside: +7.72%
May 27, 2026
Reiterated: Buy
Price Target: $237 → $205
Current: $132.84
Upside: +54.32%
May 27, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $5.75
Upside: +39.13%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $158.55
Upside: -3.50%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $26.52
Upside: -9.50%
May 15, 2026
Reiterated: Buy
Price Target: $80
Current: $86.64
Upside: -7.66%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $18.79
Upside: +6.44%
May 6, 2026
Reiterated: Hold
Price Target: $73 → $72
Current: $76.99
Upside: -6.48%
May 6, 2026
Reiterated: Buy
Price Target: $54 → $50
Current: $34.98
Upside: +42.94%
May 5, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $14.09
Upside: +13.56%
May 5, 2026
Reiterated: Sell
Price Target: $54 → $66
Current: $89.32
Upside: -26.11%
May 1, 2026
Reiterated: Hold
Price Target: $357 → $361
Current: $278.77
Upside: +29.50%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $66.46
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: $147
Current: $114.22
Upside: +28.70%
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $181.97
Upside: -8.23%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $28.46
Upside: -40.27%
Feb 10, 2026
Reiterated: Sell
Price Target: $93 → $88
Current: $91.34
Upside: -3.66%
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $75.69
Upside: n/a
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $105.80
Upside: n/a
Nov 15, 2013
Reiterated: Sell
Price Target: $103
Current: $98.99
Upside: n/a
Aug 30, 2012
Reiterated: Hold
Price Target: $44 → $15
Current: $9.54
Upside: n/a